Salta al menu principale di navigazione Salta al contenuto principale Salta al piè di pagina del sito

Saggi, Studi e Ricerche

N. 57 (2022)

Substance use disorders and psychiatric co-morbidity in the public healthcare services of Veneto Region. State of art and epidemiological data

24 November 2021


Italy has two different public healthcare services taking in care patients with dual diagnosis: (1) the mental health services (Centri di Salute Mentale – CSM) and (2) and the drug abuse services (Servizi per le Dipendenze – Ser.D.).
We collected and analyzed data regarding the frequency of the co-morbidities in Veneto Region during 2019.
Our study shows that only the 1% of the patients in treatment in the mental health services and the 8.7% of those in drug abuse services are recognized as dual diagnosed subjects. In drug abuse services the most frequent substance use disorders (SUD) correlated with a psychiatric disease were the alcohol and opioids use disorders, while the most prevalent psychiatric disorders associated with a SUD were the personality disorders and the schizophrenia, schizotypal and delusional disorders.
Our data indicate that the diagnosis of co-morbidity should be improved in both services and that integrated programs between the above services should be developed to improve the best practices.

Riferimenti bibliografici

  1. Drake R.E., Mueser K.T. (2000). Psychosocial approaches to dual diagnosis. Schizophrenia bulletin, 26(1): 105-118.
  2. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Kaplan K. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry, 61(8): 807-816.
  3. Kessler R.C., Nelson C.B., McGonagle K.A., Edlund M.J., Frank R.G., Leaf P.J. (1996). The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am. J. Orthopsychiatry, 66(1): 17-31.
  4. Kessler R.C. (2004). The epidemiology of dual diagnosis. Biol. Psychiatry, 56(10): 730-737.
  5. Kessler R.C., Berglund P., Chiu W.T., Demler O., Heeringa S., Hiripi E., Jin R., Pennell B., Walters E.E., Zaslavsky A., Zheng H. (2004). The US national comorbidity survey replication (NCS-R): design and field procedures. Inter. J. Method. Psychiatric Res., 13(2): 69-92.
  6. Maremmani A.G., Dell’Osso L., Pacini M., Popovic D., Rovai L., Torrens M., Perugi G., Maremmani I. (2011). Dual diagnosis and chronology of illness in treatment-seeking Italian patients dependent on heroin. J. Addict. Dis., 30(2): 123-135.
  7. Merikangas K.R., McClair V.L. (2012). Epidemiology of substance use disorders. Human Genetics, 131(6): 779-789.
  8. Merikangas K.R., Mehta R.L., Molnar B.E., Walters E.E., Swendsen J.D., Aguilar-Gaziola, S., Bijl R., Borges G., Caraveo-Anduaga J.J., De Wit D.J., Kolody B., Vega W.A., Wittchen H.U., Kessler R.C. (1998). Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addictive behaviors, 23(6): 893-907.
  9. Milano G., Vergani H.M., Cattedra S., Carrozzino R., Mattili F., Robbiano L., Martelli A. (2019). Co-occurring psychiatric and substance use disorders: clinical survey among a rural cohort of Italian patients. Neuropsychiatr. Dis. Treat., 15: 3454-3459.
  10. Murthy P., Mahadevan J., Chand P.K. (2019). Treatment of substance use disorders with co-occurring severe mental health disorders. Curr. Opiin. Psychiatry, 32(4): 293-299.
  11. Regione del Veneto (2011). Popolazione anno 2019. – Retrieved Novembre 10, 2021:
  12. Relazione annuale al Parlamento sul fenomeno delle tossicodipendenze in Italia anno 2021 (dati 2020) (2021).
  13. SAMSHA (Substance Abuse and Mental Health Service Administration (2018). Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health.


Caricamento metriche ...